AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Oct 28 2021
Perspectives Blog
COVID-19 Vaccines for Young Kids Near Federal Approval
Young kids in the U.S. will soon be eligible for the COVID-19 vaccine, raising questions about safety, efficacy and necessity among parents nationwide. FDA advisers this week backed a lower dose of Pfizer's vaccine for kids ages 5 to 11, and both Pfizer and Moderna recently released studies that suggest their vaccines are safe for young children. The advisers offered unanimous approval
AllSides StaffJan 26 2021
Headline Roundup
Government to Buy 200M More Vaccine Doses
President Joe Biden announced plans Tuesday to purchase 200 million more COVID-19 vaccine doses, attempting to guarantee vaccination for at least 300 million Americans by the fall. Biden's administration will buy 100 million doses each of the Pfizer-BioNTech vaccine and the Moderna vaccine, raising the current U.S. supply to about 600 million doses (both vaccine variants require two doses).
National Review (News) USA TODAY HuffPostJan 04 2022
Perspectives Blog
Media Bias Alert: Donald Trump Takes A Firm Stance On The COVID-19 Vaccine
From the CenterFormer President Donald Trump praised the COVID-19 vaccine as "one of the greatest achievements of mankind" during an interview with Candace Owens on Dec. 21, a moment that quickly went viral and sparked divisions in coverage between left- and right-rated news sources.
While Trump has spoken out against vaccine mandates and vaccinating “very young people,” he strayed
Antonio FermeNov 19 2020
Perspectives Blog
Story of the Week: Manufacturers Say COVID Vaccines are Safe, Highly Effective
Sign up here to receive the Story of the Week in your inbox every Thursday.
Amid presidential election fallout and a national surge in COVID-19 coronavirus cases, two companies, Moderna and Pfizer, both announced significant progress on coronavirus vaccines. Tests have reportedly shown both vaccines to be roughly 95% effective, and each company will soon apply for emergency use
AllSides StaffDec 16 2021
Headline Roundup
Health Authorities Discourage J&J COVID-19 Vaccine Amid Concern About Blood Clots
Health authorities and drug regulators in the U.S. are conveying more concerns about rare but severe blood clots associated with Johnson & Johnson's COVID-19 vaccine.
On Thursday, a Centers for Disease Control and Prevention (CDC) advisory panel unanimously gave a preferential recommendation to the Moderna and Pfizer-BioNTech vaccines over Johnson & Johnson's one-shot vaccine.
CNN (Online News) STAT The Epoch TimesMay 10 2021
Headline Roundup
FDA Authorizes Pfizer Vaccine For 12-15 Year Olds
The U.S. Food and Drug Administration Monday authorized Pfizer and BioNTech’s COVID-19 vaccine for emergency use in 12 to 15 year-olds. A Centers for Disease Control and Prevention (CDC) panel is set to meet Wednesday to determine how the vaccine should be administered to the age group. The FDA previously authorized emergency use of both the Pfizer and Moderna vaccines in children ages 16 and
New York Times (News) The Daily Caller USA TODAYFeb 20 2024
Headline Roundup
COVID-19 Vaccine Linked to Health Disorders in Largest Study Yet
A study of 99 million people who received the COVID-19 vaccine found that inoculated individuals were at higher risk for blood, heart, and brain-related medical issues.
The Details: The study, conducted by the Global COVID Vaccine Safety Project and published in the journal Vaccine last week, "confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré
New York Post (News) Bloomberg The HillJul 12 2021
Headline Roundup
FDA Warns Johnson & Johnson Vaccine Linked to Risk of Guillain-Barré Syndrome
On Monday the U.S. Food and Drug Administration (FDA) added a warning to the Johnson & Johnson coronavirus vaccine after data suggested the vaccine led to an increased risk of a disorder called Guillain-Barré syndrome. The Washington Post reported that after 12.8 million people were inoculated, approximately 100 people developed the neurological condition, which causes the immune system to
Reuters New York Post (News) CNN (Online News)Oct 25 2021
Headline Roundup
Perspectives: The COVID-19 Vaccine for Kids
As COVID-19 vaccines for nearly 28 million U.S. children near federal approval, parents remain divided on whether to give kids the shot.
White House coronavirus advisor Anthony Fauci said over the weekend that kids under 12 could begin getting COVID-19 shots "within the first week or two of November." The White House unveiled its plan to encourage vaccines for kids last week, and
U.S. News & World Report Fox News (Opinion) Des Moines RegisterJan 12 2021
Headline Roundup
US Ramps Up Vaccine Availability
The federal government announced updates to COVID-19 vaccine recommendations Tuesday in an effort to expand access and availability nationwide. Federal health officials are encouraging states to widen vaccination availability to people age 65 or older, and those with chronic health conditions. States won't be required to follow the guidance. The required second doses of the Pfizer-BioNTech and
Associated Press Fact Check Reuters Reason